Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 30% ± 9% |
Insufficient scRNA-seq data for expression of NR0B2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3558.24 | 226 / 226 | 97% | 138.38 | 395 / 406 |
pancreas | 100% | 753.77 | 328 / 328 | 73% | 17.55 | 130 / 178 |
stomach | 76% | 904.92 | 274 / 359 | 76% | 23.36 | 217 / 286 |
adrenal gland | 100% | 966.67 | 257 / 258 | 30% | 30.19 | 68 / 230 |
kidney | 100% | 1449.46 | 89 / 89 | 12% | 13.48 | 112 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.69 | 1 / 1 |
spleen | 99% | 572.78 | 238 / 241 | 0% | 0 | 0 / 0 |
heart | 91% | 344.87 | 787 / 861 | 0% | 0 | 0 / 0 |
intestine | 14% | 44.58 | 139 / 966 | 64% | 15.72 | 335 / 527 |
lung | 38% | 62.65 | 219 / 578 | 29% | 9.88 | 336 / 1155 |
esophagus | 0% | 0.92 | 5 / 1445 | 37% | 19.76 | 68 / 183 |
muscle | 33% | 62.01 | 261 / 803 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 19% | 4.52 | 94 / 504 |
uterus | 0% | 0 | 0 / 170 | 4% | 0.70 | 19 / 459 |
ovary | 0% | 0 | 0 / 180 | 3% | 0.41 | 15 / 430 |
thymus | 1% | 0.59 | 5 / 653 | 2% | 0.49 | 13 / 605 |
peripheral blood | 2% | 6.40 | 17 / 929 | 0% | 0 | 0 / 0 |
breast | 0% | 0.32 | 2 / 459 | 1% | 0.10 | 12 / 1118 |
adipose | 1% | 1.68 | 8 / 1204 | 0% | 0 | 0 / 0 |
skin | 0% | 0.09 | 2 / 1809 | 0% | 0.02 | 2 / 472 |
blood vessel | 0% | 0.62 | 5 / 1335 | 0% | 0 | 0 / 0 |
brain | 0% | 0.36 | 7 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0009749 | Biological process | response to glucose |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0031100 | Biological process | animal organ regeneration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045471 | Biological process | response to ethanol |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0007623 | Biological process | circadian rhythm |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0042975 | Molecular function | peroxisome proliferator activated receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR0B2 |
Protein name | Nuclear receptor subfamily 0 group B member 2 (Orphan nuclear receptor SHP) (Small heterodimer partner) |
Synonyms | SHP |
Description | FUNCTION: Transcriptional regulator that acts as a negative regulator of receptor-dependent signaling pathways (By similarity). Specifically inhibits transactivation of the nuclear receptor with which it interacts (By similarity). Inhibits transcriptional activity of NEUROD1 on E-box-containing promoter by interfering with the coactivation function of the p300/CBP-mediated transcription complex for NEUROD1 . Essential component of the liver circadian clock which via its interaction with NR1D1 and RORG regulates NPAS2-mediated hepatic lipid metabolism (By similarity). Regulates the circadian expression of cytochrome P450 (CYP) enzymes (By similarity). Represses: NR5A2 and HNF4A to down-regulate CYP2C38, NFLI3 to up-regulate CYP2A5, BHLHE41/HNF1A axis to up-regulate CYP1A2, CYP2E1 and CYP3A11, and NR1D1 to up-regulate CYP2B10, CYP4A10 and CYP4A14 (By similarity). . |
Accessions | ENST00000254227.4 Q15466 |